Verilumia 
Viking Therapeutics shares jump on weight loss drug data
Viking Therapeutics shares surged about 35.67% on Tuesday after the company reported topline results from a maintenance dosing study of VK2735, its experimental dual GLP-1 and GIP receptor agonist for obesity, showing...
